This inventor holds 1 USPTO granted patent. Top assignee: Curacyte Ag. Active years: 2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2005
Title: Sebastian Künzel: Innovator in Cardiovascular Treatments
Introduction
Sebastian Künzel is a prominent inventor based in Jena, Germany. He has made significant contributions to the field of medicine, particularly in the development of treatments for cardiovascular diseases. His innovative work has led to the creation of a highly selective inhibitor for the blood-clotting factor Xa.
Latest Patents
Sebastian Künzel holds 1 patent for his invention titled "Inhibitors for the blood-clotting factor Xa." This invention relates to derivatives of amidino-benzylamine, specifically derivatives of 4-amidino-benzylamine, which are bonded with two amino acids. These derivatives represent a novel group of highly active and selective F Xa-inhibitors aimed at treating cardiovascular diseases and thrombotic events.
Career Highlights
Künzel's career is marked by his dedication to advancing medical science. He works at Curacyte AG, where he collaborates with other talented professionals in the field. His innovative approach and commitment to research have positioned him as a key figure in the development of new therapeutic options.
Collaborations
Sebastian Künzel has worked alongside notable colleagues such as Andrea Schweinitz and Jörg Stürzebecher. Their combined expertise contributes to the success of their projects and the advancement of medical treatments.
Conclusion
Sebastian Künzel's contributions to the field of cardiovascular medicine through his innovative patents highlight his role as a leading inventor. His work continues to pave the way for new treatments that can significantly impact patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile